Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Biochemical Potency on JAK1, JAK2, JAK3 and Tyk2 from US Patent US20240209001: "HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS"
Assay data:10 Active, 10 Activity ≤ 1 µM, 10 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
assay on hold
Summary
Inhibition Tests on JAK-1, JAK-2 and JAK-3 Kinases from US Patent US11993603: "Preparation for 6-amino-1H-pyrazolo[3,4-d]pyrimidine-based JAK kinase inhibitor and application thereof"
Assay data:28 Active, 11 Activity ≤ 1 nM, 28 Activity ≤ 1 µM, 28 Tested
In Vitro JAK Kinase Assay from US Patent US11992490: "Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)"
Assay data:26 Active, 26 Activity ≤ 1 µM, 26 Tested
Biochemical Potency JAK1 Assay from US Patent US20240166651: "HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS"
Assay data:10 Active, 8 Activity ≤ 1 µM, 10 Tested
JAK2 Activity Inhibitory Assay from US Patent US20240150367: "NITROGEN-CONTAINING SPIRO CYCLIC COMPOUNDS AND PHARMACEUTICAL USE THEREOF"
Assay data:6 Active, 1 Activity ≤ 1 nM, 6 Activity ≤ 1 µM, 6 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
JAK3 Activity Inhibitory Assay from US Patent US20240150367: "NITROGEN-CONTAINING SPIRO CYCLIC COMPOUNDS AND PHARMACEUTICAL USE THEREOF"
Assay data:67 Active, 66 Activity ≤ 1 µM, 67 Tested
In Vitro JAK Kinase Assay from US Patent US11957661: "JAK1 pathway inhibitors for the treatment of vitiligo"
JAK2 Binding Assay from US Patent US20240116892: "HETEROCYCLIC AMIDE AND UREA COMPOUNDS AS JAK2 INHIBITORS"
Assay data:263 Active, 254 Activity ≤ 1 µM, 264 Tested
Radiometric Assay from US Patent US20240140952: "INHIBITORS AND DEGRADERS OF JANUS KINASE 2"
Assay data:15 Active, 9 Activity ≤ 1 nM, 15 Activity ≤ 1 µM, 15 Tested
Biochemical Kinase Assay Protocol (JAK) from US Patent US20240132525: "BORON CONTAINING PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM, METHODS AND USES THEREOF"
Assay data:90 Active, 39 Activity ≤ 1 nM, 91 Activity ≤ 1 µM, 91 Tested
ADP-Glo Kinase Assay from US Patent US20240109890: "BRIDGED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE COMPOUNDS, PREPARATION METHOD AND MEDICAL USE THEREOF"
Assay data:6 Active, 6 Activity ≤ 1 µM, 6 Tested
JAK2 Z-Lyte Biochemical Assay from US Patent US20240101559: "TRICYCLIC KINASE INHIBITORS AND USES THEREOF"
Assay data:9 Active, 1 Activity ≤ 1 µM, 11 Tested
Inhibition Activity of Compounds of the Present Invention on TYK2 JH2 Domain from US Patent US20240101548: "HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF"
Assay data:20 Active, 20 Activity ≤ 1 nM, 20 Activity ≤ 1 µM, 20 Tested
Biochemical JAK Kinase Assays from US Patent US20240092758: "IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS"
Assay data:392 Active, 381 Activity ≤ 1 nM, 392 Activity ≤ 1 µM, 392 Tested
In Vitro Test of Activities of Jak1, Jak2, Jak3, Tyk2 Kinases from US Patent US11919896: "[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof"
Assay data:14 Active, 1 Activity ≤ 1 µM, 34 Tested
Assay data:34 Active, 22 Activity ≤ 1 µM, 34 Tested
Assay data:34 Active, 34 Activity ≤ 1 µM, 34 Tested
Assay data:33 Active, 28 Activity ≤ 1 µM, 34 Tested
In Vitro JAK Kinase Assay from US Patent US11918581: "Combination therapy comprising JAK pathway inhibitor and rock inhibitor"
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on